Deodato × Mustela & Babo Botanicals

Who's actually buying your baby products?

We pulled reviews across Amazon, Walmart, iHerb, and The Bump. One pattern kept surfacing: a large, high-intent audience actively spending on both brands today, with chronic repurchase cycles and no paid acquisition behind them.

4 platforms analyzed Cross-brand signal Untapped paid media cohort

Your baby lines have a second audience, and they're finding you by accident.

Adults with eczema, lupus, autoimmune conditions, and chemo-related skin sensitivity are buying both brands' baby lines for themselves. They show up in reviews unprompted, describe clinical-level results, and recommend to others in the same situation. They're a pattern, not a fringe use case, and they represent a meaningful revenue opportunity that currently runs entirely on word of mouth.

High LTV

Chronic conditions mean chronic repurchase. These aren't one-time new-parent purchases.

Pre-sold

"Clean + gentle" reads as medical trust. Baby positioning is a signal for this group, not a barrier.

Untargeted

This cohort is arriving organically through forums and word of mouth. Paid acquisition hasn't entered the picture yet.

In their own words.

These are buyers describing real conditions: eczema, sensitivities, post-treatment skin. They reached your brand through word of mouth in condition-specific communities. None of it was driven by paid media.

"No drying alcohols, no fragrance, no essential oils — that's why I chose it."

Babo Botanicals Amazon · Adult eczema sufferer · Verified Purchase

"Her eczema cleared up within weeks. I use this after every shower."

Babo Botanicals iHerb · Adult user · Verified Purchase

Mustela · Pattern Across Reviews

Across Mustela's review set, products like Stelatopia and the Organic line generate the most emotionally intense reviews in the dataset — buyers describing resolution of conditions that "nothing else touched." The same adult-use pattern appears, particularly among reviewers managing eczema and post-chemo skin sensitivity. Neither the Organic unscented line nor the Stelatopia range is being surfaced to this cohort in paid media.

The Opportunity

A high-intent audience with a short path to conversion.

This cohort has clear search behavior, high AOV, and chronic repurchase cycles. They're reachable through paid social, programmatic, and search. Right now they find you through forums, Reddit threads, and word of mouth in condition-specific communities. A structured paid program would put that growth on a predictable curve.

Targeting is well-defined

Eczema, lupus, autoimmune, and chemo audiences are established interest segments on Meta and programmatic platforms. Supplemented with search intent and lookalikes off your existing buyers, the addressable pool is large.

The creative already exists

Your reviews are full of ad-ready copy: problem-to-solution narratives from real buyers with real conditions. A test campaign could be live within a few weeks, without a major production lift.

Incrementality is clean

This is a distinct new segment, not cannibalization of your existing parent audience. Clean holdouts make measurement straightforward, and the incremental story is easy to defend internally.

Both brands. One framework.

The signal is consistent across Mustela and Babo. A shared audience strategy with brand-appropriate creative lets you learn once and apply twice, reducing the cost of the initial test.